FDA go-ahead to test cellular rejuvenation therapy in humans

Nature Biotechnology 2026

View at publisher
DOI: 10.1038/s41587-026-03037-z
Cited by: 1

Fields of Study & Subjects

Mesenchymal stem cell research Proteoglycans and glycosaminoglycans research Biomedical Ethics and Regulation

Publication details

Journal / source
Nature Biotechnology
Publisher
Springer Science and Business Media LLC
Volume
44
Issue
2
Pages
164–164
Publication date
1 February 2026
Language
EN